» Articles » PMID: 3293523

Novel Plasmid-mediated Beta-lactamase in Clinical Isolates of Klebsiella Pneumoniae More Resistant to Ceftazidime Than to Other Broad-spectrum Cephalosporins

Overview
Specialty Pharmacology
Date 1988 May 1
PMID 3293523
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Multiresistant Klebsiella pneumoniae strains isolated from three patients in the same intensive care unit were more resistant to ceftazidime than to cefotaxime and aztreonam but remained susceptible to moxalactam and imipenem. Resistance to beta-lactams, kanamycin, streptomycin, sulfonamides, and tetracyclines was transferable to Escherichia coli by conjugation and was lost en bloc after treatment with ethidium bromide. Agarose gel electrophoresis of wild types and transconjugants indicated that these resistances were mediated by a 150-kilobase plasmid, pCFF14. The strains constitutively produced a beta-lactamase with isoelectric point close to 5.6 and which had a higher Vmax for ceftazidime and cephalothin than for cefotaxime. The substrate profile and isoelectric point of this enzyme thus differ from those of other known plasmid-mediated beta-lactamases, including the broad-spectrum enzyme CTX-1. Hybridization studies support the derivation of the novel enzyme from a TEM-type beta-lactamase.

Citing Articles

Systematic Review and Meta-analysis on Extended-Spectrum β-lactamases Producing in Nepal.

Shyaula M, Khadka C, Dawadi P, Banjara M Microbiol Insights. 2023; 16:11786361221145179.

PMID: 36655025 PMC: 9841864. DOI: 10.1177/11786361221145179.


Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.

Winkler M, Papp-Wallace K, Bonomo R J Antimicrob Chemother. 2015; 70(8):2279-86.

PMID: 25957381 PMC: 4500773. DOI: 10.1093/jac/dkv094.


Characterization of the Novel CMT Enzyme TEM-154.

Robin F, Delmas J, Machado E, Bouchon B, Peixe L, Bonnet R Antimicrob Agents Chemother. 2010; 55(3):1262-5.

PMID: 21173189 PMC: 3067075. DOI: 10.1128/AAC.01359-10.


Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.

Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R Antimicrob Agents Chemother. 2009; 54(1):466-70.

PMID: 19901092 PMC: 2798476. DOI: 10.1128/AAC.00017-09.


The bacterial Tn9 chloramphenicol resistance gene: an attractive DNA segment for Mos1 mariner insertions.

Crenes G, Ivo D, Herisson J, Dion S, Renault S, Bigot Y Mol Genet Genomics. 2008; 281(3):315-28.

PMID: 19112581 DOI: 10.1007/s00438-008-0414-6.


References
1.
Bouanchaud D, Scavizzi M, CHABBERT Y . Elimination by ethidium bromide of antibiotic resistance in enterobacteria and staphylococci. J Gen Microbiol. 1968; 54(3):417-25. DOI: 10.1099/00221287-54-3-417. View

2.
Barthelemy M, Peduzzi J, Verchere-Beaur C, Ben Yaghlane H, Labia R . Purification and biochemical properties of Pitton's type 2 beta-lactamase (SHV-1). Ann Inst Pasteur Microbiol (1985). 1986; 137B(1):19-27. DOI: 10.1016/s0769-2609(86)80090-4. View

3.
Labia R, Andrillon J, Le Goffic F . Computerized microacidimetric determination of beta lactamase Michaelis-Menten constants. FEBS Lett. 1973; 33(1):42-4. DOI: 10.1016/0014-5793(73)80154-1. View

4.
Sawai T, Yamagishi S, Mitsuhashi S . Penicillinases of Klebsiella pneumoniae and their phylogenetic relationship to penicillinases mediated by R factors. J Bacteriol. 1973; 115(3):1045-54. PMC: 246352. DOI: 10.1128/jb.115.3.1045-1054.1973. View

5.
Labia R . [Enzyme-substrate behavior. Introduction of the concept of enzymatic stability in the case of beta-lactamases]. C R Acad Hebd Seances Acad Sci D. 1974; 279(1):109-12. View